NFKB1 and Fibroadenoma: However, there are few studies evaluating the immunohistochemical expression of Nrf2 and NF-κB in women with breast cancer, and to the best of our knowledge no published research has simultaneously evaluated the expression of these biomarkers in women of reproductive age with breast cancer and fibroadenoma.